Surgery for recurrent ovarian cancer: Role of peritoneal carcinomatosis: Exploratory analysis of the DESKTOP i trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis

Annals of Surgical Oncology

Volumn 16, Issue 5, 2009, Pages 1324-1330

  Harter, P ^a   Hahmann, M ^b   Lueck, H J ^c   Poelcher, M ^d   Wimberger, P ^e   Ortmann, O ^f   Canzler, U ^g   Richter, B ^h   Wagner, U ^b   Hasenburg, A ⁱ   Burges, A ^j   Loibl, S ^k   Meier, W ^l   Huober, J ^m   Fink, D ⁿ   Schroeder, W ^o   Muenstedt, K ^p   Schmalfeldt, B ^l   Emons, G ^q   Du Bois, A ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f CARITAS KRANKENHAUS ST JOSEF   (Germany)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^h Klinikum Radebeul   (Germany)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j UNIVERSITY OF MUNICH   (Germany)

^k GOETHE UNIVERSITY   (Germany)

^l EVK Düsseldorf ^*  (Germany)

^m UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF ZURICH   (Switzerland)

^o KLINIKUM BREMEN MITTE   (Germany)

^p JUSTUS LIEBIG UNIVERSITY   (Germany)

^q UNIVERSITY OF GÖTTINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CANCER; OVERALL SURVIVAL; PROGNOSIS; SURVIVAL TIME;

DATABASES AS TOPIC; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 64249083211     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0357-0     Document Type: Article

References (29)

1. SM Eisenkop RL Friedman NM Spirtos 2000 The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma Cancer 88 144 153
2. B Gronlund L Lundvall IJ Christensen 2005 Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete reponse to paclitaxel-platinum Eur J Surg Oncol 31 67 73
3. F Jaenicke M Holscher W Kuhn 1992 Radical surgery procedure improves survival time in patients with recurrent ovarian cancer Cancer 70 2129 2136
4. MM Leitao S Kardos RR Barakat DS Chi 2004 Tertiary cytoreduction in patients with recurrent ovarian cancer Gynecol Oncol 95 181 185
5. C Scarabelli A Gallo A Carbone 2001 Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma Gynecol Oncol 83 504 512
6. EH Tay PT Grant V Gebski NF Hacker 2002 Secondary cytoreductive surgery for recurrent epithelial ovarian cancer Obstet Gynecol 99 1008 1013
7. RY Zang ZT Li J Tang 2004 Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer 100 1152 1161
8. P Benedetti Panici A De Vivo F Bellati 2007 Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer Ann Surg Oncol 14 1136 1142
9. P Harter A du Bois M Hahmann 2006 Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial Ann Surg Oncol 13 1702 1710
10. DS Chi K McCaughty JP Diaz 2006 Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent platinum-sensitive epithelial ovarian carcinoma Cancer 106 1933 1939
11. U Saygili S Guclu T Uslu O Erten E Dogan 2002 The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma Int J Gynecol Cancer 12 438 442
12. J Sehouli D Könsgen A Mustea 2003 IMO-intraoperative mapping of ovarian cancer Zentralbl Gynakol 125 129 135
13. SM Eisenkop NM Spirtos 2001 Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation between "biological aggressiveness" and survival? Gynecol Oncol 82 435 441
14. SM Eisenkop NM Spirtos 2001 What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer Gynecol Oncol 82 489 497
15. P Harter A du Bois 2005 The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence Curr Opin Oncol 17 505 514
16. Parmar MK, Lederman JA, Colombo N, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet. 2003;361:2099-106.
17. J Pfisterer M Plante I Vergote 2006 Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG J Clin Oncol 24 4699 4707
18. RE Bristow RS Tomacruz DK Armstrong EL Trimble FJ Montz 2002 Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 1248 1259
19. P Wimberger N Lehmann R Kimmig 2007 Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR) Gynecol Oncol 106 69 74
20. A du Bois M Quinn T Thigpen 2005 Consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) Ann Oncol 16 8 viii7 12
21. WE Winter III GL Maxwell CT Tian 2007 Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 25 3621 3627
22. T Onda H Yoshikawa T Yasugi M Yamada K Matsumoto J Taketani 2005 Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection Br J Cancer 92 1026 1032
23. Oksefjell H, Sandstad B, Tropé C. The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer. Ann Oncol (in press) 25 August 2008 (Epub ahead of print).
24. SM Eisenkop NM Spirtos RL Friedman 2003 Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study Gynecol Oncol 90 390 396
25. G Ferrandina F Legge V Salutari 2006 Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations Eur J Cancer 42 2296 2302
26. R Lorenz GP Krestin T Schmitz-Rixen G Arnold 1990 The significance of sonography and computed tomography for the diagnosis of the intraperitoneal spread of tumors Findings in 307 cases of peritoneal carcinosis Rofo 152 516 522
27. EL Eisenhauer NR Abu-Rustum Y Sonoda 2006 The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer Gynecol Oncol 103 1083 1090
28. EL Eisenhauer DS Chi 2007 Liver mobilization and diaphragm peritonectomy/resection Gynecol Oncol 104 2S1 25 28
29. DS Chi JP Diaz WR Jarnagin 2007 Distal partial gastrectomy and gastrojejunal anastomosis for recurrent ovarian cancer Gynecol Oncol 104 2S1 33 36